Happy with your knowledge on the reimbursement of medical devices in Germany?
Hello again, and welcome to the second post in the 3-part series on reimbursement. Last week, we focused on the reimbursement of
Tag: NUB methods
The G-BA increases the fees for consultations
Manufacturers of drugs or medical devices can apply for a consultation meeting with the G-BA before submitting a dossier. This consultation offers
G-BA assesses method of allogeneic SCT in ALL, AML and NHL
Did you know that some hospital methods are not covered by SHI funds? In Germany, non-drug interventions are assessed as methods. Methods
The process of method assessments in Germany
The G-BA, physicians, hospitals, SHI funds or patient organizations can request the assessment of a new method. If the request was accepted,
NUB method assessments to become faster
Early benefit assessments are completed within 12 months, while method assessments used to take around 3 years. In 2020, the G-BA introduced
8 NUB assessments of high-risk medical devices (§ 137h)
Hospitals can treat patients with novel methods as soon as they become available. The treatment is reimbursed by SHI funds within the
G-BA publishes an overview of all method assessments
For anyone working on German market access and / or medical devices, these G-BA news might be interesting. The link to the